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PI 3-kinase delta enhances axonal PIP3 to
support axon regeneration in the adult CNS
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Abstract
Peripheral nervous system (PNS) neurons support axon regeneration
into adulthood, whereas central nervous system (CNS) neurons lose
regenerative ability after development. To better understand this
decline whilst aiming to improve regeneration, we focused on phos-
phoinositide 3-kinase (PI3K) and its product phosphatidylinositol
(3,4,5)-trisphosphate (PIP3). We demonstrate that adult PNS neurons
utilise two catalytic subunits of PI3K for axon regeneration: p110a
and p110d. However, in the CNS, axonal PIP3 decreases with develop-
ment at the time when axon transport declines and regenerative
competence is lost. Overexpressing p110a in CNS neurons had no
effect; however, expression of p110d restored axonal PIP3 and
increased regenerative axon transport. p110d expression enhanced
CNS regeneration in both rat and human neurons and in transgenic
mice, functioning in the same way as the hyperactivating H1047R
mutation of p110a. Furthermore, viral delivery of p110d promoted
robust regeneration after optic nerve injury. These findings establish
a deficit of axonal PIP3 as a key reason for intrinsic regeneration fail-
ure and demonstrate that native p110d facilitates axon regeneration
by functioning in a hyperactive fashion.
Keywords axon transport; CNS axon regeneration; optic nerve; p110 delta;
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Introduction
Adult central nervous system (CNS) neurons have a weak capacity
for axon regeneration, meaning that injuries in the brain, spinal
cord and optic nerve have devastating consequences (He & Jin,
2016; Curcio & Bradke, 2018). In most CNS neurons, regenerative
capacity is lost as axons mature, both in vitro (Goldberg et al, 2002;
Koseki et al, 2017) and in vivo (Kalil & Reh, 1979; Wu et al, 2007).
Conversely, peripheral nervous system (PNS) neurons maintain
regenerative potential through adult life. This is partly because PNS
neurons mount an injury response in the cell body (Smith & Skene,
1997; Ylera et al, 2009; Puttagunta et al, 2014), and also because
PNS axons support efficient transport of growth-promoting recep-
tors, whilst many of these are selectively excluded from mature CNS
axons (Hollis et al, 2009a,b; Franssen et al, 2015; Andrews et al,
2016). Studies into intrinsic regenerative capacity have implicated
signalling molecules, genetic factors and axon transport pathways
as critical regeneration determinants (Park et al, 2008; Blackmore
et al, 2012; Fagoe et al, 2015; Eva et al, 2017; Weng et al, 2018;
Hervera et al, 2019). This leads to a model where axon growth
capacity is controlled by genetic and signalling events in the cell
body, and by the selective transport of growth machinery into the
axon to re-establish a growth cone after injury.
To better understand the mechanisms regulating axon regenera-
tion, we focused on the class I phosphoinositide 3-kinases (PI3Ks).
These enzymes mediate signalling through integrins, growth factor
and cytokine receptors, by producing the membrane phospholipid
PIP3 from PIP2 (phosphatidylinositol (3,4,5)-trisphosphate from
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phosphatidylinositol(4,5)-bisphosphate). Class 1 PI3Ks comprise 4
catalytic isoforms called p110a, b, c and d, with distinct roles for
some of these emerging in specific cell populations (Bilanges et al,
2019). The p110a and p110b isoforms are ubiquitously expressed,
whilst p110d and p110c are highly enriched in leucocytes (Hawkins
& Stephens, 2015). p110b and p110c have not been studied in
neurons, but p110a mediates axon growth during chick development
(Hu et al, 2013) whilst p110d is required for axon regeneration of the
PNS (Eickholt et al, 2007) and localises to the Golgi in mature corti-
cal neurons, where it controls the trafficking of the amyloid precur-
sor protein (APP) (Low et al, 2014; Martinez-Marmol et al, 2019).
The PI3K pathway is strongly implicated in the regulation of
regenerative ability because transgenic deletion of PTEN promotes
CNS regeneration (Park et al, 2008; Liu et al, 2010; Geoffroy et al,
2015). PTEN opposes PI3K by converting PIP3 back to PIP2. Addi-
tionally, inhibiting negative feedback of this pathway similarly
enhances regrowth (Al-Ali et al, 2017). These findings indicate a
pro-regenerative role for PIP3; however, this molecule has not been
directly studied in adult CNS axons. Axonal PI3K contributes to
polarity in developing hippocampal axons (Shi et al, 2003), and
PNS axons segregate PI3K at the growth cone to elicit rapid growth
(Zhou et al, 2004); however, the neuronal distribution of PIP3 is not
known. We reasoned that CNS regenerative failure might be associ-
ated with a developmental decline in PIP3 specifically within the
axon, and wondered whether individual PI3K isoforms were
required to yield sufficient axonal PIP3.
We investigated the class I PI3K isoforms and found that both
p110a and p110d are required for PNS axon regeneration and that
p110d is specifically required within the axon. In CNS neurons, we
found PIP3 was sharply downregulated with development, diminish-
ing in the axon at the time when axon transport and regeneration
also decline. We attempted to restore PIP3 through overexpression
of either p110a or p110d; however, only p110d led to elevated
axonal PIP3. Importantly, by introducing the hyperactivating
H1047R mutation into p110a we found that it could mimic the effect
of p110d, with the expression of either p110d or p110aH1047R facili-
tating axon regeneration. This suggests that regeneration is hindered
by low activation of PI3K in mature CNS axons. We found that
transgenic expression of p110d or p110aH1047R led to enhanced reti-
nal ganglion cell (RGC) survival and axon regeneration after optic
nerve crush, whilst viral expression of p110d led to stronger regen-
eration. Importantly, overexpression of p110d had both somatic and
axonal effects, enhancing the axonal transport of growth machinery
and signalling through ribosomal S6 in the cell body. These findings
demonstrate a deficit of axonal PIP3 as a novel reason for intrinsic
regenerative failure, whilst establishing that native p110d functions
in a hyperactive fashion to enable CNS axon regeneration. Our
results emphasise the importance of elevating growth-promoting
pathways in the axon as well as the cell body to stimulate axon
regeneration.
Results
Gene expression of p110 isoforms in the nervous system
Because localised axonal activation of PI3K is essential for rapid
PNS axon growth (Zhou et al, 2004), we reasoned that there may
be specific PI3K isoforms that support regeneration within PNS
axons and that these might be under-represented in CNS neurons.
p110d plays a role in PNS axon regeneration (Eickholt et al, 2007);
however, the contribution of other isoforms has not been exam-
ined. We investigated the RNA expression of the individual p110
subunits (p110a, b, c and d) in four published neuronal RNAseq
datasets (Fig EV1), examining expression in dorsal root ganglion
(DRG) neurons during axon growth and regeneration (Tedeschi
et al, 2016), in developing cortical neurons (Koseki et al, 2017)
and in the Brain-RNAseq databases (http://www.brainrnaseq.org/)
of individual cell types in mouse and human brain (Zhang et al,
2014, 2016). In DRG neurons, p110a, b and d are expressed at all
stages in vitro, whilst p110c is expressed at very low levels. p110a
is present at the highest levels, whilst p110d is upregulated in
development and further upregulated upon peripheral nerve lesion
(Fig EV1A–C). In developing cortical neurons, p110a is again
expressed at the highest levels, p110b and d are present but not
abundant, and p110c is at very low levels. Remarkably, p110a, b
and d are all downregulated as cortical neurons mature (Fig EV1D
and E). The Brain-RNAseq database indicates p110a and b are the
principal neuronal PI3K isoforms in both the mouse and human
adult brain, with p110a again expressed at the highest levels,
whilst p110d and c are enriched in microglia and macrophages
(Fig EV1F–M). These datasets indicate that p110a, b and d are
expressed in regenerative PNS neurons, but are almost absent or
downregulated with maturation in CNS neurons. We therefore
chose to investigate the contribution of the p110a, b and d
isoforms of PI3K to axon regeneration of DRG neurons.
p110a and d are required for DRG axon regeneration
We used laser axotomy to sever the axons of adult DRG neurons
and measured the effect of specific inhibitors of p110a, b and d on
growth cone regeneration (Fig 1). Inhibiting either p110a or d
reduced the percentage of axons regenerating, as did pan-PI3K
inhibition (a, b and d) or targeting p110a and d together. Inhibi-
tion of p110b had no effect, but inhibiting all of the isoforms
increased the time taken to develop a new growth cone (Fig 1A
and B and Movies EV1 and EV2). Some inhibitors also caused
uncut axons to stop growing, so we measured the extension rate
of uncut axons. Treatment with p110a inhibitors, pan-PI3K or dual
a/d inhibitors led to a dramatic reduction in the percentage of
uncut axons extending in 2 h, whilst they continued to extend in
the presence of specific p110d inhibitors (Fig 1C and D and Movies
EV3 and EV4). We next examined the effect of PI3K inhibition
using microfluidic compartmentalised chambers, in which axons
extend through microchannels into a separate compartment from
the cell bodies (Fig 1E). Inhibition of p110a or p110d showed dif-
ferent effects depending on localisation. Inhibition of p110d in the
axonal compartment reduced the percentage of regenerating axons,
but had no effect in the somatic chamber. In contrast, the p110a
inhibitor A66 reduced regeneration when applied either to the
axonal or somatic compartment, and also increased the time taken
to generate a new growth cone (Fig 1F). These data show that
DRG neurons require p110a and d for efficient regeneration. Axon
growth and regeneration require p110a activity in both the cell
body and axon, whilst axon regeneration further relies on p110d
activity specifically within the axon.
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PIP3 is developmentally downregulated in cortical neurons, but
present in adult DRG axons
The RNAseq data described above (Fig EV1) suggest that PI3K
expression increases with maturation in DRG neurons, whilst it is
downregulated as cortical neurons mature. CNS regenerative failure
might therefore be due to insufficient PI3K activity within the axon
and insufficient PIP3. PIP3 is implicated in axon growth but its
developmental distribution has not been examined. PIP3 has previ-
ously been localised using fluorescently tagged pleckstrin homology
(PH)-domain reporters, such as AKT-PH-GFP; however, the princi-
ple readout of these reporters is translocation to the surface
membrane, and they do not report on abundance or “steady-state”
distribution. To accurately measure PIP3 in neurons developing
in vitro, we optimised a fixation technique (Hammond et al, 2009)
for antibody-based PIP3 detection on immobilised membrane phos-
pholipids utilising an antibody widely used for biochemical assays.
To validate this in neurons, we isolated DRG neurons from trans-
genic mice expressing AKT-PH-GFP at low levels (Nishio et al,
2007) to avoid inhibition of downstream signalling (Varnai et al,
2005). Live imaging of adult DRG neurons from these mice revealed
dynamic hotpots of PIP3 at the axon growth cone (Fig EV2A and
Movie EV5), and membrane labelling confirmed these are not
regions of membrane enrichment (Fig EV2B and Movie EV6). Phos-
pholipid fixation and labelling with anti-PIP3 revealed colocalisation
between AKT-PH-GFP and anti-PIP3 at regions within DRG growth
cones (Fig EV2C), as well as at hotspots and signalling platforms in
non-neuronal cells from DRG cultures (Fig EV2D). In addition to
validating this technique, our data also confirm the presence of
dynamic PIP3 in the growth cone and axons of regenerative DRG
neurons. To further confirm the specificity of the stain for PIP3, we
stimulated N1E cells with insulin and labelled for PIP3 in the pres-
ence or absence of the pan-PI3K inhibitor GDC-0941, detecting
increased PIP3 staining after insulin stimulation alone, and not in
the presence of the PI3K inhibitor (Fig EV2E–G).
We then labelled E18 cortical neurons at 3, 8 and 16 days in vitro
(DIV) to detect endogenous PIP3. In immature neurons (at DIV 3),
we detected high levels of PIP3 in the cell body, and particularly in
the distal axon and growth cone (Fig 2A, D and E). At DIV 8, these
neurons have a single rapidly growing axon; at this time, there was
a sharp decline in PIP3 at the cell body (Fig 2B and D), but only a
small decrease in growth cone PIP3 (Fig 2B and E), indicating that
during the period of rapid axon extension, neurons possess high
levels of PIP3 in axonal growth cones. By DIV 16, cortical neurons
have long axons, which are establishing synapses, with some
branches still growing. These mature neurons exhibit a sharp
decline in regenerative ability and selective axon transport (Eva
et al, 2017; Koseki et al, 2017). At this stage, we detected markedly
reduced levels of PIP3 at the growth cone, whilst they remained low
at the cell body (Fig 2C–E). This indicates a global reduction in PIP3
as cortical neurons develop and demonstrates that the loss of regen-
erative ability coincides with a deficiency in axonal PIP3 production.
Expression of p110d or p110aH1047R elevates PIP3 in the soma
and axon
The results above show that PI3K and PIP3 are developmentally
downregulated in CNS axons as they lose their regenerative ability.
In DRG neurons, which continue to express PI3K and produce PIP3,
the p110a and d isoforms are necessary for efficient axon regenera-
tion (Fig 1). We therefore asked whether we could increase PIP3
levels and restore regeneration to CNS neurons by ectopic
◀ Figure 1. p110a and d are required for rat DRG axon regeneration; p110d functions in the axonal compartment.A Laser-injured DRG axons showing growth cone regeneration (upper panels) and regenerative failure (lower panels). Arrows as indicated.
B Upper graph shows percentage of regenerating axons of DIV 1–2 adult DRG neurons in the presence of p110 inhibitors, 2 h after injury. Lower graph shows time
taken to regenerate a new growth cone. Inhibitors were added 1 h before axons were injured and maintained throughout: LY294002, 20 lM; A66, 5 lM; XL-147, 5 lM;
TGX221, 500 nM; IC-87114, 10 lM; idelalisib, 500 nM. Upper graph data are shown as the mean  SEM. P-values indicate statistical significance analysed by Fisher’s
exact (upper graph) or Kruskal–Wallis test (lower graph).
C Examples of static vs. growing uninjured axons treated with p110a or d inhibitors as indicated. Both arrows in the bottom right image indicate growing axons.
D Percentage of uninjured, growing axons in the presence of p110 inhibitors. Inhibitors were added as for (B). Lower graph shows length grown in 2 h. Data are shown
as the mean  SEM. P-values indicate significance measured by Fisher’s exact test (upper graph) or ANOVA with Tukey’s post-hoc analysis (lower graph).
E Adult DRG neurons in microfluidic compartmental chambers. Cell bodies on the left side, axons extending through microchannels on the right. Lower panels are
schematics.
F Upper graph shows percentage of regenerating axons in microfluidic chambers. p110a or d inhibitors were applied to either soma or axons. Lower graph shows time
taken to regenerate a new growth cone. Inhibitors were added 1hr before axons were injured and maintained throughout: A66, 5 lM; idelalisib, 500 nM. Upper graph
data are shown as the mean  SEM. P-values indicate statistical significance as measured by Fisher’s exact test (upper graph) or by Kruskal–Wallis test (lower
graph).
Data information: Numbers on bars are the total numbers of axons cut, from n = 4 experiments for (B, D and F).
▸Figure 2. PIP3 is developmentally downregulated in rat cortical neurons maturing in vitro, first in the soma, then at the growth cone.A DIV 3 cortical neurons immunolabelled for PIP3. Spectrum heatmap shows fluorescence intensity.
B DIV 8 cortical neuron transfected with GFP and immunolabelled for PIP3. Spectrum heatmap shows fluorescence intensity.
C DIV 16 cortical neuron transfected GFP and immunolabelled for PIP3. Spectrum heatmap shows fluorescence intensity.
D Somatic PIP3 quantification in the soma at increasing days in vitro. Data are shown as the mean  SEM. P-values are significance measured by ANOVA with Tukey’s
post-hoc analysis. n = 3 experiments, 60 neurons.
E Growth cone PIP3 quantification at increasing days in vitro. Data are shown as the mean  SEM. P-values indicate significance measured by ANOVA with Tukey’s
post-hoc analysis. n = 3 experiments, 60 growth cones.
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expression of p110a, its hyperactive H1047R variant p110aH1047R
(Mandelker et al, 2009) or p110d. Previous work has shown that
p110d and p110aH1047R can sustain downstream AKT activation
upon overexpression in fibroblasts, acting independently of active
Ras, whilst native p110a does not (Kang et al, 2006). These PI3Ks
were expressed in cortical neurons at DIV 16, and PIP3 was
measured by quantitative immunofluorescence. We used dual-
promoter constructs expressing untagged p110 and GFP to avoid
potential interference of PI3K function by a protein tag.
Compared with cells expressing GFP alone, expression of p110a
had no effect on PIP3 levels in DIV 16 neurons, either in the cell
body or within the axons (Fig 3A–D). In contrast, overexpression
of either p110aH1047R or p110d led to a small but significant
increase in PIP3 in the cell body (Fig 3A and C) and a striking
increase in PIP3 at axon growth cones (Fig 3B and D). These find-
ings indicate that p110d and p110aH1047R function in a hyperactive
fashion to generate PIP3 in cortical neurons, with the strongest
effect in growth cones. However, even overexpressed p110a does
not generate PIP3, suggesting a low level of activation in mature
neurons.
Expression of p110d or p110aH1047R increases axon and
dendrite growth
We next investigated the effect of p110d, p110a or p110aH1047R
overexpression on the regulation of axon growth in cortical
neurons developing in vitro. Expression of either p110d or
p110aH1047R in immature neurons at DIV 2 led to a moderate
increase in axon length by DIV 4, compared with neurons express-
ing either GFP alone or native p110a (Fig 4A and B). p110d or
p110aH1047R expression also led to a small increase in the dendrite
length (Fig 4A and C). This led to an increase in axon/dendrite
length ratio, with axons approximately 31.5 times longer than
dendrites, whilst control neurons have axons 21.8 times longer
than dendrites. None of the PI3K isoforms therefore affected
neuronal polarisation (Fig 4A and D). We also examined the effects
of PI3K overexpression on dendrite length and branching at a later
developmental stage (transfecting at DIV 10, and analysing at DIV
14). Again, p110d and p110aH1047R behaved similarly, expression of
either construct leading to increases in both the number of dendrite
branches and the total dendrite length, compared with control-
transfected neurons. In contrast, expression of native p110a had no
effect (Fig 4E–G). The PI3K pathway is a well-known regulator of
cell size, so we also measured hypertrophy. Overexpression of
either p110d or p110aH1047R led to an increase in cell body size,
compared with either GFP or p110a (Fig 4H). To confirm down-
stream signalling through the PI3K pathway, we employed phos-
phorylation-specific immunolabelling of ribosomal S6 protein, a
transcriptional regulator routinely used as a reporter of somatic
signalling through the PI3K/AKT/mTOR pathway. p110d or
p110aH1047R expression led to a strong phospho-S6 signal compared
with GFP-expressing controls, whilst expression of p110a again had
no effect (Fig 4E and I). These findings confirm that hyperactive
p110aH1047R behaves like p110d to trigger downstream signalling
through the PI3K pathway in neuronal soma, with effects on size,
dendrite branching and axon length. The results demonstrate that
p110d and p110aH1047R enhance both axonal and dendritic growth,
whilst native p110a does not.
p110d and p110aH1047R promote axon regeneration of CNS
neurons in vitro
To determine whether activation of p110 can facilitate CNS regener-
ation, we used an in vitro model of regeneration in mature cortical
neurons, comparing overexpression of either p110d, p110a or
p110aH1047R. In this model, axon regeneration ability is progres-
sively lost with maturity, and molecules that promote regeneration
may differ from those that promote developmental outgrowth
(Koseki et al, 2017). In vitro laser axotomy was used to sever the
axons of E18 cortical neurons cultured to DIV 15–18, at which stage
they have a limited capacity for regeneration (Eva et al, 2017;
Koseki et al, 2017). Expression of either p110d or p110aH1047R led to
a sharp increase in the percentage of axons regenerating after
axotomy compared with GFP-expressing controls. p110a expression
again had no effect (Fig 5A and B and Movies EV7 and EV8).
Expression of p110d or p110aH1047R also led to an increase in the
length of regenerated axons and a trend towards shorter time of
onset to regeneration compared to controls (Fig 5C and D).
We further investigated the translational potential of p110d by
examining axon regeneration in human neurons maturing in vitro,
derived from human embryonic stem cells (hESC). We have previ-
ously demonstrated that these lose their regenerative ability in vitro
when cultured beyond 50 days (Koseki et al, 2017). Overexpression
of p110d fully restored the regenerative ability to a level observed
for younger neurons (Fig 5E and F). We observed no difference in
the length of regenerated axons compared with GFP-expressing
control neurons (Fig 5G), but there was a tendency for p110d
expressing neurons to initiate regeneration faster (Fig 5H). Overex-
pression of p110d therefore enables CNS axon regeneration in both
rat and human neurons, and this is mimicked by hyperactive
p110aH1047R, whilst overexpression of p110a is ineffective.
p110d functions through multiple downstream pathways
The data presented so far demonstrate that p110d expression
elevates axonal PIP3 and enhances axon regeneration. We
performed a series of experiments to investigate the downstream
pathways involved, focusing on mTOR, CRMP2 and ARF6. Deletion
◀ Figure 3. p110d or p110aH1047R expression elevates PIP3 in the soma and axon, whilst native p110a does not.A PIP3 immunofluorescence in the soma of DIV 16 cortical neurons expressing p110 isoforms and GFP. Spectrum heatmap shows fluorescence intensity.
B PIP3 immunofluorescence at the axonal growth cone of DIV 16 neurons expressing p110 isoforms and GFP. Spectrum heatmap shows fluorescence intensity.
C Quantification of PIP3 immunofluorescence in the soma. Data are shown as the mean  SEM. P-values indicate significance as measured by ANOVA with Tukey’s
post-hoc analysis. n = 3 experiments, 60 neurons.
D Graph showing PIP3 quantification of immunofluorescence at the axon growth cone. Data are shown as the mean  SEM. P-values indicate significance measured by
ANOVA with Tukey’s post-hoc analysis. n = 3 experiments, 60 growth cones.
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of PTEN and PI3K activity promotes regeneration by signalling
through mTOR (Park et al, 2008) and through GSK3 and CRMP2
(Leibinger et al, 2019). Deletion of PTEN or elevation of PI3K activ-
ity could also affect signalling through many molecules with PH, PX
or FYVE domains (Vanhaesebroeck et al, 2012). One molecule of
particular interest is the small GTPase ARF6, which regulates regen-
erative ability in both PNS and CNS neurons by controlling the
axonal supply of integrins in Rab11-positive endosomes, governed
by its activation state (Eva et al, 2017). In CNS neurons, axonal
ARF6 activation is maintained by two ARF6 GEFs, ARNO and EFA6,
which results in predominant retrograde transport away from the
axon (Franssen et al, 2015; Eva et al, 2017). EFA6 and ARNO inter-
act in a complicated fashion to sustain active ARF6, regulated by
their PH domains (Malaby et al, 2013; Padovani et al, 2014). We
reasoned that elevated PI3K activity might be associated with a
decrease in axonal ARF6 activation, and an increase in the antero-
grade transport of integrins in Rab11 endosomes.
We used laser axotomy and pharmacological inhibitors on mature
cortical neurons to test the contribution of mTOR and CRMP2 to the
regenerative effects of p110d, and to confirm that p110d enabled
regeneration through its kinase activity. Overexpression of p110d
again led to a robust increase in the percentage of axons regenerating
after laser injury; however, this was prevented by the presence of
the specific p110d inhibitor idelalisib, whilst the p110a inhibitor A66
had no effect (Fig 6A). To investigate the role of mTOR and CRMP2
in p110d-mediated axon regeneration, we applied rapamycin, an
inhibitor of mTOR, or lacosamide, a specific inhibitor of CRMP2,
which has been previously used to study CRMP2 and regenerative
growth in vitro (Leibinger et al, 2019). Both drugs inhibited the
regenerative effects of p110d expression to similar degrees (Fig 6A),
confirming that both pathways are functioning downstream of p110d
activity to mediate regeneration. The increase in phospho-S6
observed in p110d expressing neurons (Fig 4E) further supports the
involvement of the mTOR pathway.
We also examined the localisation of overexpressed p110d.
Endogenous p110d has been observed at the Golgi, where it controls
the trafficking of cytokines and APP (Low et al, 2010, 2014;
Martinez-Marmol et al, 2019). We did not find overexpressed p110d
enriched at any specific subcellular structures, but instead found it
distributed throughout the neuron (Fig 6B) in the somatodendritic
domain (upper panel), axon (middle panel) and axon growth cone
(lower panels), whilst being excluded from the nucleus. Overex-
pressed p110d may therefore exert its effects throughout neurons,
including at the Golgi, with the exception of the nucleus.
To investigate ARF6 activation, we visualised activated ARF6 in
the axons of DIV 16 neurons by using the ARF-binding domain
(ABD) of GGA3 fused to a GST tag, which was previously used to
measure ARF6 activation in neurons (Eva et al, 2017). Overexpres-
sion of p110d led to a reduction in ARF6 activation compared to
control neurons expressing GFP alone, whilst we detected no
change in the amount of total ARF6 protein (Fig 6C and D). We
next investigated whether the reduction of ARF6 activation was
accompanied by an increase in integrin or Rab11 transport. ARF6
controls directional transport in a complex with Rab11 (Montagnac
et al, 2009), a marker of recycling endosomes that controls
neuronal integrin traffic, as well as other growth receptors (Ascano
et al, 2009; Eva et al, 2010; Lazo et al, 2013), and contributes to
the regenerative ability of cortical neurons (Koseki et al, 2017).
We used spinning disc microscopy to image integrin dynamics in
the distal axon by visualising a9-integrin–GFP, in the presence of
mCherry (control) or mCherry plus p110d. The presence of
mCherry allows visualisation of the entire axon. Anterograde trans-
port was almost undetectable in control-transfected neurons where
we observed predominantly retrograde and static vesicles (Fig 6E
and F), in keeping with previous studies (Franssen et al, 2015).
Expression of p110d triggered anterograde movement of integrins,
leading to an increase in static integrin vesicles in the distal axon,
and an overall increase in the total number of integrin vesicles
(Fig 6G). We also analysed the dynamics of Rab11-GFP vesicles.
These moved throughout axons in an oscillatory fashion displaying
mostly bidirectional and retrograde movements, in keeping with
previous findings (Eva et al, 2017); however, expression of p110d
initiated anterograde transport and caused an increase in static and
bidirectional movements. This led to an overall increase in Rab11-
GFP vesicles in the distal part of p110d expressing axons,
compared with controls (Fig 6H–J). Expression of p110d therefore
enhances the anterograde transport of alpha9 integrins and Rab11-
positive endosomes. These transport changes may occur as a result
of a reduction in axonal ARF6 activation, although it is also possi-
ble that signalling through CRMP2 may also contribute (Rahajeng
et al, 2010). Additionally, p110d may also be functioning at the
Golgi to regulate anterograde transport, as has been shown previ-
ously (Martinez-Marmol et al, 2019). Together, our findings
demonstrate that p110d functions to support regeneration through
multiple downstream pathways, including the increased transport
of regenerative machinery.
Transgenic p110d and p110aH1047R support RGC survival and axon
regeneration in the optic nerve
To confirm whether p110d and p110aH1047R support regeneration in
the adult CNS in vivo, as we found in vitro, we used the optic nerve
◀ Figure 4. Expression of p110d or p110aH1047R increases axon and dendrite growth of rat cortical neurons developing in vitro, whilst native p110a does not.A DIV 4 cortical neurons expressing p110 isoforms and GFP. Arrow marks the axon tip.
B Quantification of axon length. n = 3 experiments, 45 neurons per group.
C Quantification of dendrite length. n = 3 experiments, 45 neurons per group.
D Quantification of the axon:dendrite length ratio. n = 3 experiments, 45 neurons per group.
E DIV 14 cortical neurons expressing p110 isoforms and GFP, immunolabelled for pS6.
F Sholl analysis of branches. n = 60 neurons per group. Data are shown as the mean  SEM. P-values indicate significance measured by repeated-measure ANOVA
with Bonferonni’s post-hoc test.
G Quantification of the total neurite length. n = 3 experiments, 60 neurons per group.
H Quantification of soma area. n = 3 experiments, 60 neurons per group.
I Quantification of the pS6 immunofluorescence. n = 3 experiments, 60 neurons per group.
Data information: (B-D and G-I) Data are shown as the mean  SEM. P-values indicate significance measured by ANOVA with Tukey’s post-hoc analysis.
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crush model to examine the effects of PI3K activation on regenera-
tion after a crush injury. We used transgenic mice, which condition-
ally express either p110d or p110aH1047R from the Rosa26 locus in
the presence of Cre recombinase (Fig 7A), and delivered AAV2-Cre-
GFP via intravitreal injection. Rosa26 allows expression of a trans-
gene at moderate levels (Nyabi et al, 2009). Two weeks after viral
injection, optic nerve crush was performed, and retinal ganglion cell
(RGC) survival and optic nerve regeneration were examined 28 days
later (Fig 7B). We tested AAV2-Cre-GFP activity using a Cre-reporter
mouse, which expresses tdTomato from the Rosa26 locus
(Fig EV3A) and confirmed expression in p110d and p110aH1047R
mice by examining GFP expression (from the viral vector) in the
retina (Fig EV3B). Activation downstream of PI3K was confirmed
by phospho-S6 immunofluorescence. Expression of either p110d or
p110aH1047R led to an increase in the number of cells labelling posi-
tive for phospho-S6; however, p110aH1047R expression led to a
slightly larger increase than p110d expression (Fig 7C and D). p110d
and p110aH1047R behaved similarly with respect to their effects on
RGC survival. The presence of transgenic p110d or p110aH1047R led
to a doubling of the number of cells surviving after 28 days (from
5.5 to 11%), demonstrating a strong neuroprotective effect (Fig 7E
and F). We then measured axon regeneration in the optic nerve and
found that p110aH1047R and p110d again behaved similarly, both
enabling a moderate increase in axon regeneration compared with
control mice injected with AAV2-Cre.GFP (Fig 7G and H). The
results confirm that p110d and p110aH1047R behave similarly in
injured RGC neurons in the CNS in vivo, enhancing RGC survival
and axon regeneration.
AAV2-p110d facilitates axon regeneration in the optic nerve
The moderate effects of transgenic p110 expression on axon regen-
eration (described above) were surprising, given the robust effects
of p110d or p110aH1047R expression on CNS axon regeneration
in vitro. We reasoned that p110 enabled axon regeneration may be
dose-dependent and that the moderate expression generated from
the Rosa26 locus (Nyabi et al, 2009) might explain these limited
effects. To test whether regeneration could be enhanced using a
viral gene transfer approach, we produced an AAV2-p110d
construct for viral transduction of RGC neurons via intravitreal
injection. We compared this with a similar AAV2-mediated shRNA
approach to silence PTEN, the phosphatase responsible for oppos-
ing the actions of PI3K by dephosphorylating PIP3 to PIP2. Trans-
genic suppression of PTEN is another means of stimulating
regeneration in the CNS, although virus-mediated shRNA silencing
has not proved to be as effective as transgenic deletion (Yungher
et al, 2015). We therefore compared viral vector-based delivery of
p110d versus viral delivery of a PTEN targeting shRNA. We first
confirmed that AAV2-shPTEN-GFP transduction resulted in silenc-
ing of PTEN in RGCs compared with AAV2-scrambled-GFP control,
PTEN levels being measured by quantitative immunofluorescence
(Fig EV4A and B). We confirmed transduction of RGCs by AAV2-
p110d immunofluorescence, comparing p110d with RGC neurons
transduced with AAV2-GFP (Fig EV4C and D). We examined down-
stream signalling by labelling for ribosomal phospho-S6. Transduc-
tion with AAV2-shPTEN-GFP led to an increase in the percentage
of transduced cells labelling positive for phospho-S6 compared with
AAV2-scrambled-GFP-transduced neurons (from 27% for controls
to 48% for PTEN silenced; Fig 8A and B). Due to the lack of a tag
on AAV2-p110d (due to potential effects on activity), we measured
the total number of TUJ1 labelled neurons that also labelled for
phospho-S6. Transduction with AAV2-p110d led to an increase in
phospho-S6-positive neurons compared with AAV2-GFP-transduced
controls (1140 cells for p110d transduced, compared with 650 cells
for GFP transduced) (Fig 8A and C).
Having validated the two approaches, we next compared their
effects on RGC survival and axon regeneration after optic nerve
crush. Silencing of PTEN led to a robust increase in the survival of
RGC neurons compared with controls at 28 days after crush (14.7%
of PTEN-silenced neurons survived compared to 4.9% of control
neurons), whilst transduction with p110d led to a smaller effect on
survival (11.3% of p110d-transduced neurons compared 6.3% of
GFP control neurons; Fig 8D and E), similar to the amount observed
due to transgenic expression (Fig 7F). We examined CTB-traced
RGC axon regeneration in the optic nerve and found that both
AAV2-mediated silencing of PTEN and AAV2 delivery of p110d
enhanced axon regeneration. Transduction with p110d had the most
robust effects on regeneration, with 180 axons counted at 0.5 mm
into the optic nerve, compared with 25 axons in control-injected
mice (Fig 8F). Injection of AAV2-shPTEN-GFP led to 97 axons at
0.5 mm, again compared with 25 axons for controls (this compares
with 60 axons for p110d, 70 for p110aH1047R with transgenic expres-
sion). AAV2-p110d also enabled axons to regenerate further into the
optic nerve reaching a maximum distance of 3 mm, whilst silencing
of PTEN enabled axons to reach a maximum of 1.5 mm (transgenic
expression of p110aH1047R and p110d also gave 1.5 mm regenera-
tion). These data demonstrate that the PI3K pathway can be targeted
to stimulate RGC survival and axon regeneration either by
◀ Figure 5. p110d and p110aH1047R promote axon regeneration of CNS neurons in vitro.A Axotomised DIV 14–16 rat cortical neurons expressing p110d and GFP or GFP alone. Axons were cut > 1,000 lm from the soma imaged for 14 h. Black arrows mark
the cut site, and white arrows mark the axon tip. See also Movies EV7 and EV8.
B Percentage of regenerating axons 14 h after laser axotomy. Numbers on bars are injured axons per group, from 4 experiments.
C Quantification of axon regeneration length 14 h post-axotomy. n = 9 axons for GFP, 9 for p110a, 25 for p110aH1047R and 27 for p110d from 4 experiments.
D Quantification of time to start of regeneration. n = 9 axons for GFP, 9 for p110a, 25 for p110aH1047R and 27 for p110d from 4 experiments.
E Axotomised human embryonic stem cell neurons p110d and GFP or GFP alone. Black arrow marks the cut site, and white arrows mark the axon tip.
F Percentage of regenerating axons of human hESC neurons. Numbers on bars are injured axons per group, from 5 experiments.
G Quantification of axon regeneration length. n = 22 axons for GFP, 44 for p110d, from 5 experiments. Data are shown as the mean  SEM. Data were analysed by
two-tailed Student’s t-test.
H Quantification of time to start of regeneration. n = 22 axons for GFP, 44 for p110d, from 5 experiments. Data are shown as the mean  SEM. Data were analysed by
two-tailed Student’s t-test.
Data information: (B–D and F), Data are shown as the mean  SEM. P-values indicate significance measured by ANOVA with Tukey’s post-hoc analysis.
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expressing p110d or by silencing PTEN, but that expression of
p110d has the most robust effects on axon regeneration. Together,
these data show that enhancing PI3K activity in CNS neurons
greatly enhances their ability to regenerate their axons and indicate
viral delivery of p110d to CNS neurons as a novel approach to boost
signalling through this regenerative pathway.
Discussion
Our study aimed to find a new method of stimulating axon regenera-
tion based on manipulation of PIP3 levels in neurons. In previous
work, the approach to this has mainly been to knock down the PIP3
dephosphorylating enzyme PTEN (Park et al, 2008; Liu et al, 2010;
Lee et al, 2014; Geoffroy et al, 2015). However, this approach
depends on generation of PIP3 by PI3K, and if there is little PIP3
being produced, PTEN knockdown will have little effect. We
reasoned that limited PIP3 production in mature neurons would
explain the observation that PTEN knockout is effective at promot-
ing axon regeneration in immature neurons, less so in the fully adult
CNS. We used a new method to visualise PIP3 levels in PNS and
CNS neurons at different levels of maturity. In sensory axons, which
regenerate readily, we observed high levels of PIP3 in the growth
cones, dynamically changing with growth cone movements. In corti-
cal CNS neurons, developing immature neurons exhibited intense
PIP3 levels in their axon and growth cone during the period of rapid
axon growth. However, PIP3 levels decreased to a much lower level
at a time when transport declines and axons lose their capacity for
regeneration. We also investigated the role of PI3K isoforms in
regeneration in PNS neurons using isoform-specific inhibitors. In
sensory axons, which regenerate successfully and quickly, growing
in microfluidic chambers to separate axonal and cell body compart-
ments, inhibitors of p110a blocked both growth and post-axotomy
regeneration when applied to either compartment, but a p110d inhi-
bitor blocked regeneration without affecting normal growth. This
supports a previous study that links p110d to sensory regeneration
(Eickholt et al, 2007) and suggests that p110d is uniquely linked to
regeneration. Overexpression of p110 isoforms was therefore tested
for the ability to increase PIP3 levels and to promote regeneration.
Overexpression of p110d in mature CNS neurons partially restored
PIP3 levels, particularly in axon tips but p110a was ineffective.
However, introducing the hyperactivating H1047R mutation to
p110a had the same effect on PIP3 levels as p110d.
Stimulation of axon regeneration was therefore assessed. p110d
and p110aH1047R transfected into mature cortical neurons strongly
enhanced axon regeneration. In the CNS in vivo, transgenic expres-
sion led to enhanced neuroprotection in the retina, and regeneration
in the optic nerve after a crush injury. Importantly, viral transduc-
tion of p110d (which produces a higher level of expression) into
adult RGC neurons led to axons regenerating for a greater distance
after injury, demonstrating a novel approach to boost CNS regenera-
tion through the PI3K pathway by gene transfer. Previous work has
indicated that the hyperactive H1047R mutation of p110a can
behave like p110d to sustain AKT signalling in fibroblasts, by func-
tioning independently of co-activation by Ras (Kang et al, 2006).
We found that expression of native p110a had no effect on PIP3
generation; it was only p110d or p110aH1047R that enhanced axonal
PIP3 (Fig 3). This suggests that receptor activation of PI3K is at a
low level in mature CNS neurons and that p110d can potentiate
PI3K signalling in low trophic conditions that are insufficient to acti-
vate native p110a. Our findings suggest that p110d has a lower
threshold of activation and that signals normally required to fully
activate p110a (such as adhesion and growth factor receptors or
Ras) may not be available in the axon. This has important implica-
tions for understanding the nature of p110d beyond the nervous
system and may help to explain how T cells utilise p110d for devel-
opment, differentiation and function (Okkenhaug, 2013).
The PI3K signalling pathway is a well-known regulator of axon
regeneration, based on seminal studies which demonstrated that
deletion of PTEN leads to robust regeneration in the CNS through
downstream signalling via mTOR (Park et al, 2008). Aside from
mTOR, the mechanism through which PTEN deletion stimulates
regeneration is not completely understood. One difficulty in under-
standing its mechanism is that in addition to functioning as a lipid
phosphatase (PTEN opposes PI3K by converting PIP3 back to PIP2),
it also has protein phosphatase activity (Kreis et al, 2014). It is now
also apparent that PTEN not only dephosphorylates PI(3,4,5)P3, but
also functions as a PI(3,4)P2 phosphatase, a role linked with cancer
◀ Figure 6. p110d functions through multiple downstream pathways.A Percentage of regenerating axons after laser axotomy of DIV 14–17 rat cortical neurons expressing either GFP (control) or GFP and p110d in the presence of the
indicated inhibitors, 14h after laser injury. Numbers on bars are injured axons per group.
B Single confocal section through a DIV 16 neuron expressing p110d and GFP (upper panels). Green colour is GFP, and red is overexpressed p110d, detected with anti-
p110d. Lower panels show p110d and GFP in a distal axon section, and at the growth cone. Arrow indicates the axon.
C Active ARF and total ARF6 (red) in axons of DIV 16 rat cortical neurons expressing GFP or GFP and p110d, as indicated. Arrows indicate axons.
D Quantification of mean axonal ARF activity and total (mean) ARF6 in DIV 16 neurons expressing GFP or GFP and p110d n = 60 axons for each condition.
E Kymographs showing dynamics of a9 integrin–GFP in the distal axons of DIV 14–16 neurons, control or co-transfected with p110d.
F Quantification of a9 integrin–GFP dynamics in the distal axons of DIV 14–16 neurons, control or co-transfected with p110d. n numbers are axon sections analysed for
each condition.
G Quantification of total a9 integrin–GFP number in the distal axons of DIV 14–16 neurons, control or co-transfected with p110d. n = 43 for control, 47 for co-
transfected with p110d. n numbers are axon sections analysed for each condition.
H Kymographs showing dynamics of Rab11–GFP in the distal axons of DIV 14–16 neurons, control or co-transfected with p110d.
I Quantification of Rab11–GFP dynamics in the distal axons of DIV 14–16 neurons, control or co-transfected with p110d. n numbers are axon sections analysed for
each condition.
J Quantification of total Rab11–GFP in the distal axons of DIV 14–16 neurons, control or co-transfected with p110d. n = 43 for control, 53 for co-transfected with
p110d. n numbers are axon sections analysed for each condition.
Data information: Data are shown as the mean  SEM. (A) P-values indicate statistical significance analysed by Fisher’s exact test. (F and I) P-values indicate
significance measured by ANOVA with Tukey’s post-hoc analysis. (D, G and J). Data were analysed by two-tailed Student’s t-test.
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invasion (Malek et al, 2017). Our findings argue in favour of PTEN
functioning through the regulation of PIP3 and confirm the impor-
tance of this molecule in the regulation of axon regeneration.
Most PI3K signalling events rely on more than one isoform
(Hawkins & Stephens, 2015), and whilst the p110d isoform contri-
butes to sciatic nerve regeneration (Eickholt et al, 2007), the contri-
bution of the other isoforms remained unknown. Our findings
demonstrate that both p110a and d are required for efficient axon
regeneration and that p110a functions in both the axon and cell
body, whilst p110d is specifically required in the axon (Fig 1). Inhi-
bition of p110a opposed both axon growth and regeneration, whilst
the action of p110d was specific to regeneration, with the p110d
inhibitor blocking regeneration but not growth of uncut axons. This
is in keeping with previous studies of the kinase-inactive p110dD910A
transgenic mouse, which has normal nervous system development,
but defective PNS regeneration (Eickholt et al, 2007). Taken
together, these results suggest that p110a mediates the somatic and
axonal signalling that is necessary to support adult DRG axon
growth (itself a regenerative phenomenon), whilst p110d is further
required within the axon to facilitate the redevelopment of a growth
cone after injury. In CNS neurons, overexpression of either p110d or
p110aH1047R was sufficient to enable efficient regeneration both
in vitro and in vivo, and AAV-mediated p110d expression in RGCs
promoted robust optic nerve regeneration.
Our studies into the downstream pathways mediating the effects
of p110d overexpression suggest the involvement of multiple path-
ways, including signalling through mTOR and CRMP2, which have
previously been implicated in mediating the regenerative effects of
PTEN deletion and PI3K activity (Park et al, 2008; Leibinger et al,
2019). Both of these pathways function downstream of AKT, which
is recruited to PIP3 by virtue of its PH domain. It is likely that
additional pathways could contribute to regeneration downstream
of either PIP3 generation or PIP2 reduction, due to the wide variety
of proteins with PH domains, including the regulatory molecules of
small GTPases that regulate the cytoskeleton, such as Rac1 and
Cdc42 (Welch et al, 2002; Yoshizawa et al, 2005; Sosa et al, 2006),
or that regulate axon transport such as ARF6 (Gillingham &
Munro, 2007; Nieuwenhuis & Eva, 2018). Our findings suggest that
p110d exerts some of its effects by signalling through ARF6, a
known regulator of integrin and Rab11 transport (Montagnac et al,
2009; Ghosh et al, 2019). These molecules contribute to the devel-
opmental loss of CNS regenerative ability, becoming transported
away from axons and restricted to the dendrites and cell body as
CNS neurons mature (Franssen et al, 2015; Koseki et al, 2017).
Overexpression of p110d led to a restoration of anterograde trans-
port of both integrins and Rab11 endosomes. The direction of
Rab11 transport is likely regulated in a complex with ARF6,
although it may potentially be regulated by activation state or by
phosphoinositide generation (Campa & Hirsch, 2017). Previous
work has shown that forcing Rab11 vesicles into these mature
axons promotes regeneration (Koseki et al, 2017). Rab11 is also
associated with the transport of other PI3K activating receptors,
which are excluded from mature axons (Hollis et al, 2009a,b).
Increased receptor transport due to p110d expression suggests a
feed-forward mechanism, in keeping with previous findings that
BDNF stimulation leads to increased axonal transport of TrkB
receptors during development (Cheng et al, 2011). Newly trans-
ported integrins could potentially signal through p110d, as has
previously been shown in PNS neurons (Eickholt et al, 2007) and
cancer cells (Fiorcari et al, 2013).
The exclusion of PI3K-activating receptors from mature axons is
probably a reason why the generation of PIP3 is low in mature
axons, and why overexpression of p110a in neurons did not
increase PIP3 levels. PTEN deletion and p110d expression also
enhance regeneration via mTOR signalling in the cell body;
however, mTOR has recently been found to be present at the growth
cone of developing axons in the mouse cerebral cortex, suggesting
the PI3K-AKT-mTOR pathway may also function locally within the
axon (Poulopoulos et al, 2019). Our findings demonstrate the
importance of PIP3 in the axon as well as the cell body for optimal
regeneration. The importance of targeting the axon as well as the
cell body is often overlooked; however, there is increased axonal
transport as part of the PNS injury response, and in the CNS,
increased transport enables regeneration (Petrova & Eva, 2018).
The search for methods for promoting regeneration in the
damaged CNS continues. A successful strategy will likely involve
multiple interventions. Could manipulation of PI3K be useful? PTEN
deletion or p110aH1047R expression can be oncogenic in dividing
cells. However, expression under a neuron-specific promoter targets
expression to a non-dividing cell type, and it is unlikely that expres-
sion of p110d in CNS neurons would lead to cell transformation,
particularly given its usual expression in PNS neurons. Our study
puts forward AAV-mediated delivery of p110d as a novel means of
stimulating regeneration through the PI3K pathway. We propose
that p110d should also be considered as an additional intervention
with other regenerative strategies that target the PI3K pathway,
either through growth factor treatments such as IGF-1 plus osteo-
pontin (Duan et al, 2015; Liu et al, 2017), expression of activated
◀ Figure 7. p110d and p110aH1047R support RGC survival and axon regeneration in the mouse optic nerve.A Schematic representation of Rosa26 transgene expression via AAV.Cre recombinase.
B Time course of optic nerve regeneration experiments using Rosa26 p110aH1047R and Rosa26 p110d mice.
C Retinal sections from AAV-injected mice, immunolabelled for phospho-S6. Blue colour is DAPI to indicate nuclei. Inset images show individual colours at the same
scale as the full image.
D Percentage of phospho-S6-positive cells in the RGC layer 2 weeks after delivery of AAV-Cre-GFP or AAV-GFP.
E Retinal whole-mounts of AAV-injected mice immunolabelled for the RGC marker Brn3A to indicate cell survival.
F Analysis of RGC survival 28 days after optic nerve crush (counts of Brn3A-positive RGC neurons).
G Representative images of CTB-labelled RGC axons 4 weeks after optic nerve crush in wild-type (c57bl/6), Rosa26-p110aH1047R and Rosa26-p110d transgenic mice
injected with AAV2.Cre.GFP. Dashed line indicates crush site.
H Regenerating axons at different distances distal to lesion sites.
Data information: (D, F and H) Data are shown as the mean  SEM. P-values indicate significance as measured by ANOVA with Tukey’s post-hoc analysis. n = 7 mice
(wt), 10 mice (p110aH1047R) and 6 mice (p110d).
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integrins (Cheah et al, 2016), or through pharmacological interven-
tions such as insulin (Agostinone et al, 2018).
Materials and Methods
Mouse strains
C57BL6/J mice were used during this study, as well as four
transgenic mouse strains: GFP-AKT-PH, Rosa26 p110aH1047R,
Rosa26 p110d and B6;129S6-Gt(ROSA)26Sortm14(CAG-tdTo-
mato)Hze/J (https://www.jax.org/strain/007908). The genera-
tion of the PIP3 reporter mouse GFP-AKT-PH has been
previously described (Nishio et al, 2007) and was a gift from
Dr Len Stephens (Babraham Institute, UK). Male and female
mice were used dependent on litters available with equal distri-
butions across experiments. Rosa26 p110aH1047R and Rosa26
p110d were generated according to a previously described
protocol (Nyabi et al, 2009). Briefly, cDNA sequences for
human p110a or p110d were cloned into the pENTR D-TOPO
vector (Thermo Fisher) to allow cloning into Gateway-compa-
tible vectors. The H1047R point mutation was introduced by
site-directed mutagenesis into PIK3CA using the QuickChange II
XL kit (Stratagene #200521) and the primers QuickChange
H1047R forward 50-catgaaacaaatgaatgatgcacgccatggtggctggacaac-30
and QuickChange H1047R reverse 50-gttgtccagccaccatggcgtgcat-
cattcatttgtttcatg. The presence of the mutation was confirmed
by sequencing prior to cloning into the destination vector.
PIK3CD (p110d) was a gift from Roger Williams (MRC Labora-
tory for Molecular Biology, UK). PIK3CA (p110a) was a gift
from Bert Vogelstein (Addgene plasmid #16643; http://n2t.net/add
gene:16643; RRID:Addgene_16643; Samuels et al, 2004). The Gate-
way-compatible pROSA26 destination vector (pROSA26-DV1) was
a gift from Jody Haigh (University of Manitoba, Canada; Nyabi
et al, 2009). Targeting constructs harbouring sequences for
p110aH1047R or p110d were used to electroporate Bruce4 C57BL/6
ES cells. Selection of targeted clones was undertaken with G418,
making use of the neomycin resistance selection cassette. Posi-
tively targeted clones were identified by Southern blotting. Posi-
tively targeted clones were microinjected into C57BL/6J-Tyrc-2J
blastocysts by Babraham Institute Gene Targeting Facility (Babra-
ham Institute, UK). These blastocysts were transferred to the
oviducts of time-mated pseudopregnant foster mothers. The
progeny were assessed for their degree of chimerism by coat
colour and chimeric males mated to white C57BL/6J-Tyrc-2J
females. Black progeny were tested for their correct incorporation
of the Human PI3K genes at the Rosa26 locus by PCR using the
following primers:
DRG culture
Dissociated DRG neuronal cultures were obtained from adult male
Sprague Dawley (SD) rats and from the transgenic AKT-PH-GFP
adult mouse. DRGs were incubated with 0.1% collagenase in
Dulbecco’s modified Eagle’s medium (DMEM) for 90 min at 37°C
followed by 10 min in trypsin at 37°C and dissociated by tritura-
tion. Dissociated cells were centrifuged through a layer of 15%
bovine serum albumin (BSA) and cultured on 1 lg/ml laminin on
glass-bottom dishes (Greiner) in DMEM supplemented with 10%
foetal calf serum and 50 ng/ml nerve growth factor (NGF). For
compartmentalised experiments, DRG neurons were plated in
Xona microfluidic devices (Xona SND150) on glass coverslips. For
PI3K inhibitor experiments, media were exchanged for serum-free
media overnight. Separation of media was achieved by maintain-
ing a pressure gradient between the axonal and somatic sides of
the device.
◀ Figure 8. AAV2-p110d facilitates axon regeneration in the mouse optic nerve.A Retinal sections from mice injected with AAV2 viruses as indicated, immunolabelled for phospho-S6. Blue colour is DAPI to indicate nuclei. Inset images show
individual colours at the same scale as the full image.
B Percentage of phospho-S6-positive cells in the retinal ganglion layer of mice injected with AAV2.shScramble.GFP or AAV2.shPTEN.GFP.
C Number of pS6-positive RGCs of mice injected with AAV2.GFP or AAV2.p110d.
D Representative images of retinal whole-mounts from AAV-injected mice stained for the RGC marker Brn3A to indicate RGC survival.
E RGC survival 28 days after optic nerve crush.
F CTB-labelled RGC axons 4 weeks after optic nerve crush. Boxes i. to iv. show regenerating axons. Dashed line indicates crush site. White arrows mark the end of
axons. Graph shows quantification of regenerating axons at different distances distal to the lesion sites.
Data information: (B) and (C) Data are shown as the mean  SEM and P-values indicate significance measured by two-tailed Student’s t-test. (E and H) Data are shown
as the mean  SEM and P-values indicate significance measured by ANOVA with Tukey’s post-hoc analysis. n = 8 mice (scrambled shRNA control) 6 mice (shPTEN) 4
mice (GFP) and 7 mice (p110d).
Rosa26 ROSA26 F1 AMQ GGCTCAGTTGGGCTGTTTTG WT allele = 359 bp
Hs p110 ROSA26 R2 AMQ TCTGTGGGAAGTCTTGTCCC KI allele = 603 bp
ROSA26 loxP AMQ GTGGATGTGGAATGTGTGCG
Hs p110a Hs PIK3CA #5 intra fwd TTGATCTTCGAATGTTACCT KI allele = 813 bp
S2rev CTTGATATCGAATTCCGCCCC
Hs p110d Hs PIK3CD #5 intra fwd GTACTCCGTTCAGACACCAT KI allele = 742 bp
S2rev CTTGATATCGAATTCCGCCCC
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Embryonic cortical neuron culture
Primary rat cortical neuron culture has been described previously
(Eva et al, 2017). Cultures were prepared from embryonic day 18
(E18) SD rats. Neurons were dissociated with papain for 8 min at
37°C, washed with HBSS and cultured in MACS Neuro Medium
supplemented with MACS NeuroBrew (Miltenyi), and plated on
glass-bottom dishes (Greiner) coated with poly-D-lysine. Cells were
transfected at 10 DIV, and experiments were performed between
DIV 14 and 17. Cortical neurons were transfected with magnetic
nano-particles (Franssen et al, 2015).
hESC dopaminergic neuron culture
RC17 hESC cell culture has been previously described in detail
before (De Sousa et al, 2016; Koseki et al, 2017). Cells (RRID:
CVCL_L206) were sourced from Roslin Cells, Scottish Centre for
Regenerative Medicine, Edinburgh, UK. The cell line is free from
mycoplasma contamination as determined by RT–qPCR. On d0,
hESC were detached and transferred to form embryoid bodies from
d0 to d4 in neural induction medium (Neurobasal:DMEM/F12
(1:1), 0.2% P/S, L-glutamine, N2, B27, recombinant Sonic Hedge-
hog Shh (C24II), recombinant noggin (Ng), SB431542 (SB) and
CHIR99021 (CH)). Rock inhibitor (RI,) was present in the medium
from d0 to d2. At d4, embryoid bodies were plated in poly-L-
ornithine laminin and fibronectin (PLF)-coated plates and cultured
in neural proliferation medium (Neurobasal:DMEM/F12 (1:1),
0.5xN2, 0.5xB27, supplemented with Shh, Ng, SB and CH from d4
to d7, and with Shh, Ng and CH from d7 to d9). At d11, cells were
dissociated with Accutase and 50*104 cells per well single-cell
suspensions were plated in PLF-coated 8-well chamber slides. Cells
were cultured in neuronal differentiation medium (NB with 0.2%
P/S, l-glutamine, B27, ascorbic acid, recombinant human BDNF,
GDNF, db-CAMP; 50 mM) and DAPT from d14 onwards. Medium
was replaced twice weekly up to day 50, after which medium was
replaced weekly.
N1E cell culture
N1E-115 cells (ATCC) were plated at a density of 5,000 cells/cm² in
DMEM-high glucose with GlutaMAX (Gibco) + 10% FBS and incu-
bated for 6–7 h at 5% CO2 and 37°C.
DNA constructs
Constructs for expressing p110 were generated from pHRsinUbEm,
a bicistronic vector expressing EGFP under the control of the SFFV
promoter and emerald fluorescent protein under the control of the
Ubiquitin promoter. p110d (PIK3CD) was a gift from Roger
Williams (MRC Laboratory for Molecular Biology, UK). PIK3CD was
cloned from pcDNA3.1 in place of EGFP. p110a (PIK3CA) or p110a
H1047R was cloned into the same site from pBabe puro vectors.
pBabe puro HA PIK3CA and p110a H1047R were gifts from Jean
Zhao (Addgene plasmid #12522 and #12524; http://n2t.net/addge
ne:12522; RRID:Addgene_12522, http://n2t.net/addgene:12524;
RRID:Addgene_12524) (Zhao et al, 2005). AAV.CAG.p110d was
generated by cloning the human PIK3CD sequence into an AAV-
sCAG vector backbone by Gibson assembly (Gibson et al, 2009).
Antibodies
The antibodies were as follows: PI(3,4,5)P: anti-PtdIns(3,4,5)P3
monoclonal antibody (Z-P345b, 1:200, Echelon Biosciences), GFP
(rabbit, 1:500 Abcam ab290), phospho-S6 ribosomal protein
(Ser235/236) (91B2) (rabbit, 1:200, Cell Signaling 4857S), TUJ1 (bIII
Tubulin) (mouse, 1:400, Promega G7121), PTEN (D4.3) XP (rabbit,
1:100, Cell Signaling 9188S), p110d (rabbit, 1:500, Abcam ab1678),
Brn3a (C-20) (goat, 1:200, Santa Cruz sc-31984). ARF6, (rabbit,
1:100, Abcam ab77581), GST (1:400, Abcam ab19256), anti-goat
Alexa Fluor 647 (1:1,000, A21447, Life Technologies), anti-rabbit
IgG-conjugated Alexa Fluor 568 (A10042, 1:1,000, Thermo Fisher
Scientific), anti-mouse IgG-conjugated Alexa Fluor 568 (A11004,
1:1,000, Thermo Fisher Scientific), anti-rabbit IgG-conjugated Alexa
Fluor 488 (A-21206, 1:1,000, Thermo Fisher Scientific) and anti-
mouse IgG-conjugated Alexa Fluor 488 (A-21202, 1:1,000, Thermo
Fisher Scientific).
Small-molecule inhibitors
The following small-molecule inhibitors were used to inhibit the
various isoforms of p110. The indicated concentrations were chosen
based on their known IC50 and from previously reported cell culture
experiments: Pan-p110 (p110a/b/d): LY294002, 20 lM (IC50 (in
cell-free assays) 0.5 lM/0.97 lM/0.57 lM, respectively); p110a:
A66, 5 lM (IC50 32 nM); p110a/d: XL-147, 5 lM (IC50 39 nM/
36 nM); p110b: TGX221, 500 nM (IC50 5 nM); p110d: IC-87114,
10 lM (IC50 0.5 lM); p110d: idelalisib, 500 nM (IC50 2.5 nM),
lacosamide, 5 lm (Leibinger et al, 2019), and rapamycin, 20 nm
(IC50 0.1 nM). DMSO was added at a volume corresponding to
volume of inhibitor used in the experimental condition, to a maxi-
mum of 5 ll (in a final volume of 3 ml culture media).
Virus production and injection
Three viruses were sourced commercially: AAV2.CMV.Cre.GFP
(Vector Biolabs, Catalog #7016), AAV2.CMV.GFP (Vigene Bios-
ciences, Catalog #CV10004) and AAV2.U6.shRNA (scram-
ble).CMV.GFP (SignaGen Laboratories, Catalog #SL100815).
AAV2.U6.shPTEN.CMV.GFP was a gift from Zhigang He (Boston
Children’s Hospital), and AAV2.CAG.p110delta was produced by
Vigene Biosciences. Mice received 2 ll intravitreal injections of
AAV. All viruses were injected into the left eye only at 1 × 1013 GC/
ml. For validation experiments, mice also received intravitreal injec-
tion of the appropriate control into the right eye.
Optic nerve injury
Optic nerve injuries were carried out as previously described (Smith
et al, 2009). The optic nerve behind the left eye was exposed
intraorbitally and crushed with fine forceps for 10 s, approximately
0.5 mm behind the optic disc. Twenty-six days after the injury, mice
received a 2 ll intravitreal injection of cholera toxin subunit b
(CTB) with an Alexa Fluor 555 conjugate at 1 mg/ml. Twenty-eight
days post-crush, animals were perfused with 4% paraformaldehyde
(PFA) and the eyes and optic nerves collected for analysis. Surgical
procedures were performed under anaesthesia using intraperitoneal
injection of ketamine (100 mg/kg) and xylazine (10 mg/kg). This
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research was regulated under the Animals (Scientific Procedures)
Act 1986 Amendment Regulations 2012 following ARRIVE guideli-
nes and ethical review by the University of Cambridge Animal
Welfare and Ethical Review Body (AWERB). We also followed the
Association for Research in Vision and Ophthalmology’s Statement
for the Use of Animals in Ophthalmic and Visual Research. Research
was carried out on UK Home Office Project Licence 70/8152 under
protocols 3 (breeding) and 4 (ocular injections and injury). Mice
had unrestricted access to food and water and were maintained on a
12-h light/dark cycle in groups of five. Adult (2–6 months) male
and female mice were used dependent on litters available with equal
distributions across experiments. The sample size used in each
experiment is stipulated in the figure legends.
Immunohistochemistry
Retinas were fixed in 4% PFA for 2 h. Whole-mounts were washed
four times with 0.5% PBS-Triton X-100. In between the second and
third wash, a permeation step was performed to improve antibody
penetration by freezing the retinas in 0.5% PBS-Triton X-100 for
10 min at 70°C, and washing was continued after thawing. Optic
nerves were fixed overnight at 4°C in 4% PFA, followed by 30%
sucrose overnight at 4°C. Sections were blocked with 2% BSA and
10% donkey serum in 2% PBS-Triton X-100. Primary antibodies
were incubated at 4°C overnight and secondary antibodies for 2 h at
room temperature.
Standard immunocytochemistry
Cortical neurons were fixed with 3% paraformaldehyde (PFA) in
PBS for 15 min and permeabilised with 0.1% Triton X-100 in PBS
for 5 min. Cells were blocked with 3% bovine serum albumin (BSA)
in PBS for 1 h. After blocking, the cells were incubated with primary
antibodies diluted in 3% BSA in PBS at 4°C overnight and secondary
antibodies that were diluted in 3% BSA in PBS for 1 h at room
temperature.
Phospholipid fixation and immunocytochemistry
We adapted a fixation technique previously used to detect PI(4,)P2
and PI(4,5)P2 (Hammond et al, 2009). Cortical neuron cultures were
fixed using pre-warmed (37°C) 3% formaldehyde and 0.2%
glutaraldehyde (GA; G011/3, TAAB Laboratories) in PBS for 15 min
at room temperature, washed in 50 mM NH4Cl in PBS and then
maintained at 4°C. Cells were incubated with 4°C blocking and
permeabilisation solution (0.2% saponin, 50 mM NH4Cl and 3%
BSA in PBS) for 30 min and then with anti-PtdIns(3,4,5)P3 (Z-
P345b, 1:200, Echelon Biosciences) in blocking solution for 3 h
before washing three times in 50 mM NH4Cl for 30 min. The
secondary antibody was applied for 2 h at 4°C. After another 30-min
wash, cells were post-fixed in 3% formaldehyde in PBS for 5 min at
4°C before being moved to room temperature for a further 10 min.
Axonal ARF6 activation assay
Active ARF protein was detected using a previously established
protocol (Eva et al, 2017) by means of a peptide derived from the
active ARF-binding domain (ABD) of GGA3 fused to a GST tag
(GGA3–ABD–GST, Thermo Fisher Scientific). Neurons were fixed
for 15 min in 3% formaldehyde (TAAB) in PBS, permeabilised with
0.1% Triton X-100 for 2 min and incubated with 20 lg/ml GGA3–
ABD–GST in TBS and 1 mM EDTA overnight at 4°C. The GST tag
was then detected using rabbit anti-GST antibody (ab19256, Abcam,
1:400). Control and experimental cultures were fixed and labelled in
parallel, using identical conditions. Axons were analysed at 200–
1,000 lm distal to the cell body. Images of axons were acquired by
confocal laser-scanning microscopy using a Leica TCS SPE confocal
microscope. Detection settings were adjusted so that the pixel inten-
sities of acquired images were below saturation. Settings were then
stored and were applied for the identical acquisition of each image
using Leica LAS AF software. Lines were then traced along sections
of axons to define the region of interest, and mean pixel intensities
per axon section were quantified using Leica LAS AF. Images were
corrected for background by subtracting an identical adjacent region
of interest. The same technique was then used for measuring total
levels of ARF6 in axons, after ARF6 immunolabelling.
Insulin stimulation of N1E cells
Cells were starved in DMEM without serum overnight in the pres-
ence of either 500 nM GDC-0941 (Selleckchem) or an equal volume
of cell culture grade DMSO (AppliChem). Cells were stimulated with
20 lg/ml insulin (Sigma) in DMEM or control treated with equal
amounts of DMEM for 1 min prior to fixation in PIP3-Immobilisation
fixative and stained with for PIP3 (anti-PIP3, Echelon) and F-actin
(Phalloidin, Thermo Fisher Scientific).
Confocal and widefield microscopy
Laser-scanning confocal microscopy was performed using a Leica
DMI4000B microscope and a Leica TCS SPE confocal system
controlled with Leica LAS AF. Fluorescence and widefield micro-
scopy were performed using a Leica DMI6000B with a Leica DFC350
FX CCD camera and a Leica AF7000 with a Hamamatsu EM CCD
C9100 camera and Leica LAS AF. Leica AF7000 was used for imag-
ing of axon and growth cone regeneration after axotomy.
TIRF microscopy
Total internal reflection fluorescence (TIRF) microscopy was carried
out on a Leica DMI6000B adapted with a dedicated TIRF module
from Rapp OptoElectronic. GFP was excited with a 488 nm laser,
and images were acquired using a Leica Plan Apo 100×/NA1.47 Oil
TIRF objective and Hamamatsu EM CCD C9100 camera controlled
by Leica LAS AF and Rapp OptoElectronic software.
Laser axotomy of DRG neurons
Laser axotomy of DRG neurons was performed as described previ-
ously (Eva et al, 2017). Axons were cut directly before a growth
cone, to determine the proportion of axons that regenerate rapidly
after injury. Cultures were serum-starved overnight, and inhibitors
were added at the start of the experiment. Preliminary experiments
confirmed there was no effect of DMSO on the rate of regeneration,
by comparing DMSO vs. no DMSO conditions. Axons were severed
using a 355 nm DPSL laser (Rapp OptoElectronic, Hamburg,
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Germany) connected to a Leica DMI6000B, and images were
acquired every 15 min for 2 h. Successful regeneration was deter-
mined as the development and extension of a new growth cone.
Laser axotomy of cortical neurons
Laser axotomy of cortical neurons was performed as described
previously (Eva et al, 2017; Koseki et al, 2017) Axons were severed
using a 355 nm DPSL laser (Rapp OptoElectronic, Hamburg,
Germany) connected to a Leica DMI6000B. Cortical neurons were
axotomised at DIV 14–17 at distances of 800–2,000 lm from the cell
body on a section of axon free from branches. Images after axotomy
were acquired every 30 min for 14 h. Regeneration was classed as
the development of a new growth cone followed by axon extension
for a minimum of 50 lm.
Laser axotomy of hESC-derived neurons
Laser axotomy of hESC-derived neurons was performed as described
previously (Koseki et al, 2017). Axons were severed using a 365 nm
laser (MicroPoint, Andor) connected to an Andor spinning disk
confocal microscope. Neurons were axotomised at d45–65 at
distances of > 500 lm distal to the cell body on a section of axon
free from branches. A single axon cut was made per neuron. Images
after axotomy were acquired every 20 min for 16 h. Regeneration
was classed as the development of a new growth cone followed by
axon extension for a minimum of 50 lm.
Quantification of PIP3 in cortical neurons
E18 cortical neurons were fixed at DIV 3, 8 or 16, and PIP3 was
detected as described above. All cultures were fixed and labelled
using identical conditions. Images were acquired by confocal
laser-scanning microscopy using a Leica TCS SPE confocal micro-
scope. Identical settings were used for each image using Leica
LAS AF. Z-stacks were acquired for each image, spanning the
entire depth of either the cell body or the growth cone. PIP3 fluo-
rescence intensity was measured using Leica LAS AF. Immunoflu-
orescence intensities were calculated by measuring the region of
interest (ROI) and subtracting the intensity of a control region
adjacent to the ROI.
Quantification of PIP3 in N1E cells
Imaging was performed on a Leica SP5 confocal system with a 40×
objective with identical settings across experiments. Stacks covered
the complete height of all cells with. Areas with comparable cell
densities were selected in the F-actin channel. Mean PIP3 intensity
in N1E cells was quantified in Fiji (ImageJ 1.51n) on max projec-
tions. Intensities were compared in 15 images per treatment from
three independent cultures.
Analysis of neuronal morphology
Images were captured on a Leica DMI6000B, with a 40X-oil objec-
tive using Leica LAS AF. Semi-automated and standardised analysis
was performed using MATLAB platform version 2017 and SynD
(Schmitz et al, 2011). The output of SynD was used for data
analysis of dendritic length, fluorescent intensities, sholl analysis
and soma size.
Neurite outgrowth assay
Cultured cortical neurons were transfected at 2 DIV and fixed at 4
DIV. Images for neuronal morphology were acquired using a Leica
DMI6000B microscope, with a 40X-oil objective using Leica LAS AF.
Neurite lengths were measured using the ImageJ plugin “simple
neurite tracer” (Longair et al, 2011).
Axon transport analysis
Axon transport analysis of integrins and Rab11 has been described
in detail before (Franssen et al, 2015; Eva et al, 2017). Briefly, corti-
cal neurons were transfected at DIV 10 with a9 integrin–GFP, or
Rab11–GFP together with either mCherry (control) or mCherry plus
p110d, and imaged at DIV 14–16 DIV using spinning disc confocal
microscopy. Sections of axons were imaged at a region in the distal
part of the axon (> 800 lm from the cell body). Vesicles were
tracked for their visible lifetime and analysed by kymography to
classify the proportion of vesicles classed as anterograde, retro-
grade, bidirectional or immobile per axon section. Vesicles with a
total movement less than 2 lm during their visible lifetimes were
classed as immobile. Vesicles moving in both directions but with
net movement of < 2 lm (during their visible lifetimes) were
classed as bidirectional. Vesicles with net movements > 5 lm in
either direction by the end of their visible lifetimes were classed as
anterograde or retrograde accordingly.
Optic nerve regenerating axon counts
To measure regenerating RGC axons after optic nerve crush, longitu-
dinal sections of optic nerves were serially collected. Regenerating
RGC axons were quantified as described previously (Smith et al,
2009), by counting the number of CTB-labelled axons at the indi-
cated distances beyond the crush site from four sections per optic
nerve. Axonal sections were imaged using a Zeiss AxioScan Z1 at
×40 magnification.
RGC survival counts
For retinal whole-mounts, two images were taken from each of the
four retinal quadrants at ×20 magnification, sampling both the more
central and the more peripheral region of each quadrant. Images
were then analysed in ImageJ Fiji using Image-Based Tool for
Counting Nuclei (ITCN) Plugin (University of California, Santa
Barbara, CA, USA) to count Brn3A-labelled cells. The number of
RGCs in the left injured eye was expressed as a percentage survival
value compared to the mean number of RGCs of the contralateral
control eyes.
RGC fluorescence analysis
To confirm successful viral transduction, eye cup images were
stained for GFP or PI3KDelta counterstained with DAPI and imaged
using a Zeiss AxioScan Z1 at ×20 magnification. Retinal sections
immunolabelled for pS6 were examined by fluorescence
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microscopy. One hundred GFP-positive RGCs were counted and
identified as positive or negative for pS6. For AAV2.p110d-trans-
duced RGCs, the total number of pS6-positive cells was counted
from 12 retinal sections throughout the eye compared to total
number of pS6-positive cells from the control group using TUJ1 to
identify neurons. Fluorescence intensity was measured using ImageJ
Fiji.
Quantitative and statistical analysis
Statistical analysis was performed throughout using GraphPad
Prism. Fisher’s exact test was calculated using GraphPad online
(https://www.graphpad.com/quickcalcs/contingency1.cfm).
Percentage of regenerating axons was compared by Fisher’s exact
test. Sample size calculations using data from previous experiments
and pilot studies were used to minimise the group sizes required to
demonstrate clinically relevant (as opposed to simply statistically
significant) effect sizes. Animals of both sexes were chosen
randomly, different viral treatments were assigned to animals
randomly, and analysis and quantification were blinded. Normality
was tested for with GraphPad Prism software, using the
D’Agostino–Pearson normality test, when appropriate. Kruskal–
Wallis and Fisher’s exact test were used as indicated in the
manuscript. Variation was tested using the Brown–Forsythe test
using GraphPad Prism. Comparisons between more than two experi-
mental groups (e.g. expression of various PI3K isoforms) and one
measured variable were done using one-way ANOVA to test for
variance and Tukey’s multiple comparison test.
Data and software availability
This study includes no data deposited in external repositories.
Expanded View for this article is available online.
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The paper explained
Problem
Young neurons in the central nervous system (CNS) can regrow their
axons after injury, but this ability is lost as they mature. Axonal injury
or disease in the adult brain, eyes and spinal cord therefore has
devastating consequences, and can result in neurological impairment,
vision loss or paralysis. Conversely, neurons of the peripheral nervous
system (PNS) maintain the ability to regenerate their axons into
adulthood. Comparing PNS and CNS neurons is one approach to iden-
tifying new ways of promoting injured CNS axons to regenerate after
injury.
Results
Our study found that adult PNS neurons use two versions of the
enzyme PI 3-kinase to regenerate their axons, p110d and p110a.
These enzymes generate the phospholipid PIP3. Visualisation of PIP3 in
maturing CNS neurons revealed that PIP3 is strongly downregulated
at the time when these neurons lose their regenerative ability. Over-
expression of p110d elevated axonal PIP3 and regeneration after laser
injury, but p110a required the activating H1047R mutation to behave
similarly, demonstrating that native p110d functions in a hyperactive
fashion. The study found that p110d functioned through multiple
mechanisms, including the enhanced transport of regenerative
machinery into axons. Importantly, viral delivery of p110d to the
retina promoted axon regeneration after an optic nerve crush injury
and was accompanied by enhanced survival of RGC neurons in the
retina.
Impact
These findings suggest that signalling through PI 3-kinase-linked
receptors is limited in adult CNS axons, contributing to their weak
regenerative ability. Exogenous expression of the p110d subunit
elevates axonal PI 3-kinase activity by functioning in a hyperactive
fashion, leading to enhanced regeneration in human and rodent
models of CNS injury, and enhanced neuroprotection and regenera-
tion after a mouse optic nerve crush injury.
ª 2020 The Authors EMBO Molecular Medicine 12: e11674 | 2020 21 of 24
Bart Nieuwenhuis et al EMBO Molecular Medicine
(vii) Fight for Sight: https://www.fightforsight.org.uk/
(viii) International Spinal Cord Society: https://www.iscos.org.uk/
(ix) Christopher and Dana Reeve Foundation: https://www.christopherreeve.org/
(x) Spinal Research: https://www.spinal-research.org/
(xi) Wings for Life: https://www.wingsforlife.com/en/
References
Agostinone J, Alarcon-Martinez L, Gamlin C, Yu WQ, Wong ROL, Di Polo A
(2018) Insulin signalling promotes dendrite and synapse regeneration and
restores circuit function after axonal injury. Brain 141: 1963 – 1980
Al-Ali H, Ding Y, Slepak T, Wu W, Sun Y, Martinez Y, Xu XM, Lemmon VP,
Bixby JL (2017) The mTOR substrate S6 Kinase 1 (S6K1) is a negative
regulator of axon regeneration and a potential drug target for central
nervous system injury. J Neurosci 37: 7079 – 7095
Andrews MR, Soleman S, Cheah M, Tumbarello DA, Mason MR, Moloney E,
Verhaagen J, Bensadoun JC, Schneider B, Aebischer P et al (2016) Axonal
localization of integrins in the CNS is neuronal type and age dependent.
eNeuro https://doi.org/10.1523/ENEURO.0029-16.2016
Ascano M, Richmond A, Borden P, Kuruvilla R (2009) Axonal targeting of Trk
receptors via transcytosis regulates sensitivity to neurotrophin responses. J
Neurosci 29: 11674 – 11685
Bilanges B, Posor Y, Vanhaesebroeck B (2019) PI3K isoforms in cell signalling
and vesicle trafficking. Nat Rev Mol Cell Biol 20: 515 – 534
Blackmore MG, Wang Z, Lerch JK, Motti D, Zhang YP, Shields CB, Lee JK,
Goldberg JL, Lemmon VP, Bixby JL (2012) Kruppel-like Factor 7 engineered
for transcriptional activation promotes axon regeneration in the adult
corticospinal tract. Proc Natl Acad Sci USA 109: 7517 – 7522
Campa CC, Hirsch E (2017) Rab11 and phosphoinositides: a synergy of signal
transducers in the control of vesicular trafficking. Adv Biol Regul 63:
132 – 139
Cheah M, Andrews MR, Chew DJ, Moloney EB, Verhaagen J, Fassler R,
Fawcett JW (2016) Expression of an activated integrin promotes long-
distance sensory axon regeneration in the spinal cord. J Neurosci 36:
7283 – 7297
Cheng PL, Song AH, Wong YH, Wang S, Zhang X, Poo MM (2011) Self-
amplifying autocrine actions of BDNF in axon development. Proc Natl
Acad Sci USA 108: 18430 – 18435
Curcio M, Bradke F (2018) Axon regeneration in the central nervous system:
facing the challenges from the inside. Annu Rev Cell Dev Biol 34: 495 –
521
De Sousa PA, Tye BJ, Bruce K, Dand P, Russell G, Collins DM, Greenshields A,
McDonald K, Bradburn H, Allan D et al (2016) Derivation of the clinical
grade human embryonic stem cell line RCe021-A (RC-17). Stem Cell Res
17: 1 – 5
Duan X, Qiao M, Bei F, Kim IJ, He Z, Sanes JR (2015) Subtype-specific
regeneration of retinal ganglion cells following axotomy: effects of
osteopontin and mTOR signaling. Neuron 85: 1244 – 1256
Eickholt BJ, Ahmed AI, Davies M, Papakonstanti EA, Pearce W, Starkey ML,
Bilancio A, Need AC, Smith AJ, Hall SM et al (2007) Control of axonal
growth and regeneration of sensory neurons by the p110delta PI 3-kinase.
PLoS ONE 2: e869
Eva R, Dassie E, Caswell PT, Dick G, Ffrench-Constant C, Norman JC,
Fawcett JW (2010) Rab11 and its effector Rab coupling protein
contribute to the trafficking of beta 1 integrins during axon growth in
adult dorsal root ganglion neurons and PC12 cells. J Neurosci 30:
11654 – 11669
Eva R, Koseki H, Kanamarlapudi V, Fawcett JW (2017) EFA6 regulates selective
polarised transport and axon regeneration from the axon initial segment. J
Cell Sci 130: 3663 – 3675
Fagoe ND, Attwell CL, Kouwenhoven D, Verhaagen J, Mason MR (2015)
Overexpression of ATF3 or the combination of ATF3, c-Jun, STAT3 and
Smad1 promotes regeneration of the central axon branch of sensory
neurons but without synergistic effects. Hum Mol Genet 24: 6788 – 6800
Fiorcari S, Brown WS, McIntyre BW, Estrov Z, Maffei R, O’Brien S, Sivina M,
Hoellenriegel J, Wierda WG, Keating MJ et al (2013) The PI3-kinase delta
inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of
chronic lymphocytic leukemia (CLL) cell to endothelial and marrow
stromal cells. PLoS ONE 8: e83830
Franssen EH, Zhao RR, Koseki H, Kanamarlapudi V, Hoogenraad CC, Eva R,
Fawcett JW (2015) Exclusion of integrins from CNS axons is regulated by
Arf6 activation and the AIS. J Neurosci 35: 8359 – 8375
Geoffroy CG, Lorenzana AO, Kwan JP, Lin K, Ghassemi O, Ma A, Xu N, Creger
D, Liu K, He Z et al (2015) Effects of PTEN and nogo codeletion on
corticospinal axon sprouting and regeneration in mice. J Neurosci 35:
6413 – 6428
Ghosh M, Lo R, Ivic I, Aguilera B, Qendro V, Devarakonda C, Shapiro LH (2019)
CD13 tethers the IQGAP1-ARF6-EFA6 complex to the plasma membrane to
promote ARF6 activation, beta1 integrin recycling, and cell migration. Sci
Signal 12: eaav5938
Gibson DG, Young L, Chuang RY, Venter JC, Hutchison CA III, Smith HO (2009)
Enzymatic assembly of DNA molecules up to several hundred kilobases.
Nat Methods 6: 343 – 345
Gillingham AK, Munro S (2007) The small G proteins of the Arf family and
their regulators. Annu Rev Cell Dev Biol 23: 579 – 611
Goldberg JL, Klassen MP, Hua Y, Barres BA (2002) Amacrine-signaled loss of
intrinsic axon growth ability by retinal ganglion cells. Science 296:
1860 – 1864
Hammond GR, Schiavo G, Irvine RF (2009) Immunocytochemical techniques
reveal multiple, distinct cellular pools of PtdIns4P and PtdIns(4,5)P(2).
Biochem J 422: 23 – 35
Hawkins PT, Stephens LR (2015) PI3K signalling in inflammation. Biochim
Biophys Acta 1851: 882 – 897
He Z, Jin Y (2016) Intrinsic control of axon regeneration. Neuron 90: 437 – 451
Hervera A, Zhou L, Palmisano I, McLachlan E, Kong G, Hutson TH, Danzi MC,
Lemmon VP, Bixby JL, Matamoros-Angles A et al (2019) PP4-dependent
HDAC3 dephosphorylation discriminates between axonal regeneration and
regenerative failure. EMBO J 38: e101032
Hollis ER II, Jamshidi P, Low K, Blesch A, Tuszynski MH (2009a) Induction of
corticospinal regeneration by lentiviral trkB-induced Erk activation. Proc
Natl Acad Sci USA 106: 7215 – 7220
Hollis ER II, Lu P, Blesch A, Tuszynski MH (2009b) IGF-I gene delivery
promotes corticospinal neuronal survival but not regeneration after adult
CNS injury. Exp Neurol 215: 53 – 59
Hu Y, Poopalasundaram S, Graham A, Bouloux PM (2013) GnRH neuronal
migration and olfactory bulb neurite outgrowth are dependent on FGF
receptor 1 signaling, specifically via the PI3K p110alpha isoform in chick
embryo. Endocrinology 154: 388 – 399
Kalil K, Reh T (1979) Regrowth of severed axons in the neonatal central
nervous system: establishment of normal connections. Science 205:
1158 – 1161
Kang S, Denley A, Vanhaesebroeck B, Vogt PK (2006) Oncogenic
transformation induced by the p110beta, -gamma, and -delta isoforms
of class I phosphoinositide 3-kinase. Proc Natl Acad Sci USA 103:
1289 – 1294
22 of 24 EMBO Molecular Medicine 12: e11674 | 2020 ª 2020 The Authors
EMBO Molecular Medicine Bart Nieuwenhuis et al
Koseki H, Donegá M, Lam BYH, Petrova V, van Erp S, Yeo GSH, Kwok JCF,
Ffrench-Constant C, Eva R, Fawcett J (2017) Selective Rab11 transport and
the intrinsic regenerative ability of CNS axons. Elife 6: e26956
Kreis P, Leondaritis G, Lieberam I, Eickholt BJ (2014) Subcellular targeting and
dynamic regulation of PTEN: implications for neuronal cells and
neurological disorders. Front Mol Neurosci 7: 23
Lazo OM, Gonzalez A, Ascano M, Kuruvilla R, Couve A, Bronfman FC (2013)
BDNF regulates Rab11-mediated recycling endosome dynamics to induce
dendritic branching. J Neurosci 33: 6112 – 6122
Lee DH, Luo X, Yungher BJ, Bray E, Lee JK, Park KK (2014) Mammalian target
of rapamycin’s distinct roles and effectiveness in promoting compensatory
axonal sprouting in the injured CNS. J Neurosci 34: 15347 – 15355
Leibinger M, Hilla AM, Andreadaki A, Fischer D (2019) GSK3-CRMP2 signaling
mediates axonal regeneration induced by Pten knockout. Commun Biol 2:
318
Liu K, Lu Y, Lee JK, Samara R, Willenberg R, Sears-Kraxberger I, Tedeschi A,
Park KK, Jin D, Cai B et al (2010) PTEN deletion enhances the regenerative
ability of adult corticospinal neurons. Nat Neurosci 13: 1075 – 1081
Liu Y, Wang X, Li W, Zhang Q, Li Y, Zhang Z, Zhu J, Chen B, Williams PR,
Zhang Y et al (2017) A sensitized IGF1 treatment restores corticospinal
axon-dependent functions. Neuron 95: 817 – 833 e814
Longair MH, Baker DA, Armstrong JD (2011) Simple Neurite Tracer: open
source software for reconstruction, visualization and analysis of neuronal
processes. Bioinformatics 27: 2453 – 2454
Low PC, Misaki R, Schroder K, Stanley AC, Sweet MJ, Teasdale RD,
Vanhaesebroeck B, Meunier FA, Taguchi T, Stow JL (2010) Phosphoinositide
3-kinase delta regulates membrane fission of Golgi carriers for selective
cytokine secretion. J Cell Biol 190: 1053 – 1065
Low PC, Manzanero S, Mohannak N, Narayana VK, Nguyen TH, Kvaskoff D,
Brennan FH, Ruitenberg MJ, Gelderblom M, Magnus T et al (2014)
PI3Kdelta inhibition reduces TNF secretion and neuroinflammation in a
mouse cerebral stroke model. Nat Commun 5: 3450
Malaby AW, van den Berg B, Lambright DG (2013) Structural basis for
membrane recruitment and allosteric activation of cytohesin family
Arf GTPase exchange factors. Proc Natl Acad Sci USA 110:
14213 – 14218
Malek M, Kielkowska A, Chessa T, Anderson KE, Barneda D, Pir P, Nakanishi H,
Eguchi S, Koizumi A, Sasaki J et al (2017) PTEN regulates PI(3,4)P2
signaling downstream of class I PI3K. Mol Cell 68: 566 – 580.e510
Mandelker D, Gabelli SB, Schmidt-Kittler O, Zhu J, Cheong I, Huang CH,
Kinzler KW, Vogelstein B, Amzel LM (2009) A frequent kinase domain
mutation that changes the interaction between PI3Kalpha and the
membrane. Proc Natl Acad Sci USA 106: 16996 – 17001
Martinez-Marmol R, Mohannak N, Qian L, Wang T, Gormal RS, Ruitenberg
MJ, Vanhaesebroeck B, Coulson EJ, Meunier FA (2019) p110delta PI 3-
kinase inhibition perturbs APP and TNFalpha trafficking, reduces plaque
burden, dampens neuroinflammation and prevents cognitive decline in an
Alzheimer’s disease mouse model. J Neurosci 39: 7976 – 7991
Montagnac G, Sibarita JB, Loubery S, Daviet L, Romao M, Raposo G, Chavrier
P (2009) ARF6 Interacts with JIP4 to control a motor switch mechanism
regulating endosome traffic in cytokinesis. Curr Biol 19: 184 – 195
Nieuwenhuis B, Eva R (2018) ARF6 and Rab11 as intrinsic regulators of
axon regeneration. Small Gtpases https://doi.org/10.1080/21541248.2018.
1457914
Nishio M, Watanabe K, Sasaki J, Taya C, Takasuga S, Iizuka R, Balla T,
Yamazaki M, Watanabe H, Itoh R et al (2007) Control of cell polarity
and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1. Nat Cell Biol 9:
36 – 44
Nyabi O, Naessens M, Haigh K, Gembarska A, Goossens S, Maetens M, De
Clercq S, Drogat B, Haenebalcke L, Bartunkova S et al (2009) Efficient
mouse transgenesis using Gateway-compatible ROSA26 locus targeting
vectors and F1 hybrid ES cells. Nucleic Acids Res 37: e55
Okkenhaug K (2013) Signaling by the phosphoinositide 3-kinase family in
immune cells. Annu Rev Immunol 31: 675 – 704
Padovani D, Folly-Klan M, Labarde A, Boulakirba S, Campanacci V, Franco M,
Zeghouf M, Cherfils J (2014) EFA6 controls Arf1 and Arf6 activation
through a negative feedback loop. Proc Natl Acad Sci USA 111:
12378 – 12383
Park KK, Liu K, Hu Y, Smith PD, Wang C, Cai B, Xu B, Connolly L, Kramvis I,
Sahin M et al (2008) Promoting axon regeneration in the adult CNS by
modulation of the PTEN/mTOR pathway. Science 322: 963 – 966
Petrova V, Eva R (2018) The virtuous cycle of axon growth: Axonal transport
of growth-promoting machinery as an intrinsic determinant of axon
regeneration. Dev Neurobiol 78: 898 – 925
Poulopoulos A, Murphy AJ, Ozkan A, Davis P, Hatch J, Kirchner R, Macklis JD
(2019) Subcellular transcriptomes and proteomes of developing axon
projections in the cerebral cortex. Nature 565: 356 – 360
Puttagunta R, Tedeschi A, Soria MG, Hervera A, Lindner R, Rathore KI, Gaub P,
Joshi Y, Nguyen T, Schmandke A et al (2014) PCAF-dependent epigenetic
changes promote axonal regeneration in the central nervous system. Nat
Commun 5: 3527
Rahajeng J, Giridharan SS, Naslavsky N, Caplan S (2010) Collapsin response
mediator protein-2 (Crmp2) regulates trafficking by linking endocytic
regulatory proteins to dynein motors. J Biol Chem 285: 31918 – 31922
Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A,
Powell SM, Riggins GJ et al (2004) High frequency of mutations of the
PIK3CA gene in human cancers. Science 304: 554
Schmitz SK, Hjorth JJ, Joemai RM, Wijntjes R, Eijgenraam S, de Bruijn P,
Georgiou C, de Jong AP, van Ooyen A, Verhage M et al (2011) Automated
analysis of neuronal morphology, synapse number and synaptic
recruitment. J Neurosci Methods 195: 185 – 193
Shi SH, Jan LY, Jan YN (2003) Hippocampal neuronal polarity specified by
spatially localized mPar3/mPar6 and PI 3-kinase activity. Cell 112: 63 – 75
Smith DS, Skene JH (1997) A transcription-dependent switch controls
competence of adult neurons for distinct modes of axon growth. J
Neurosci 17: 646 – 658
Smith PD, Sun F, Park KK, Cai B, Wang C, Kuwako K, Martinez-Carrasco I,
Connolly L, He Z (2009) SOCS3 deletion promotes optic nerve regeneration
in vivo. Neuron 64: 617 – 623
Sosa L, Dupraz S, Laurino L, Bollati F, Bisbal M, Caceres A, Pfenninger KH,
Quiroga S (2006) IGF-1 receptor is essential for the establishment of
hippocampal neuronal polarity. Nat Neurosci 9: 993 – 995
Tedeschi A, Dupraz S, Laskowski CJ, Xue J, Ulas T, Beyer M, Schultze JL, Bradke
F (2016) The calcium channel subunit Alpha2delta2 suppresses axon
regeneration in the adult CNS. Neuron 92: 419 – 434
Vanhaesebroeck B, Stephens L, Hawkins P (2012) PI3K signalling: the
path to discovery and understanding. Nat Rev Mol Cell Biol 13:
195 – 203
Varnai P, Bondeva T, Tamas P, Toth B, Buday L, Hunyady L, Balla T (2005)
Selective cellular effects of overexpressed pleckstrin-homology domains
that recognize PtdIns(3,4,5)P3 suggest their interaction with protein
binding partners. J Cell Sci 118: 4879 – 4888
Welch HC, Coadwell WJ, Ellson CD, Ferguson GJ, Andrews SR, Erdjument-
Bromage H, Tempst P, Hawkins PT, Stephens LR (2002) P-Rex1, a PtdIns
(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor
for Rac. Cell 108: 809 – 821
ª 2020 The Authors EMBO Molecular Medicine 12: e11674 | 2020 23 of 24
Bart Nieuwenhuis et al EMBO Molecular Medicine
Weng YL, Wang X, An R, Cassin J, Vissers C, Liu Y, Liu Y, Xu T, Wang X, Wong
SZH et al (2018) Epitranscriptomic m(6)A regulation of axon regeneration
in the adult mammalian nervous system. Neuron 97: 313 – 325 e316
Wu Z, Ghosh-Roy A, Yanik MF, Zhang JZ, Jin Y, Chisholm AD (2007)
Caenorhabditis elegans neuronal regeneration is influenced by life stage,
ephrin signaling, and synaptic branching. Proc Natl Acad Sci USA 104:
15132 – 15137
Ylera B, Erturk A, Hellal F, Nadrigny F, Hurtado A, Tahirovic S, Oudega M,
Kirchhoff F, Bradke F (2009) Chronically CNS-injured adult sensory
neurons gain regenerative competence upon a lesion of their peripheral
axon. Curr Biol 19: 930 – 936
Yoshizawa M, Kawauchi T, Sone M, Nishimura YV, Terao M, Chihama K,
Nabeshima Y, Hoshino M (2005) Involvement of a Rac activator, P-Rex1,
in neurotrophin-derived signaling and neuronal migration. J Neurosci 25:
4406 – 4419
Yungher BJ, Luo X, Salgueiro Y, Blackmore MG, Park KK (2015) Viral vector-
based improvement of optic nerve regeneration: characterization of
individual axons’ growth patterns and synaptogenesis in a visual target.
Gene Ther 22: 811 – 821
Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O’Keeffe S, Phatnani HP,
Guarnieri P, Caneda C, Ruderisch N et al (2014) An RNA-sequencing
transcriptome and splicing database of glia, neurons, and vascular cells of
the cerebral cortex. J Neurosci 34: 11929 – 11947
Zhang Y, Sloan SA, Clarke LE, Caneda C, Plaza CA, Blumenthal PD, Vogel
H, Steinberg GK, Edwards MS, Li G et al (2016) Purification and
characterization of progenitor and mature human astrocytes reveals
transcriptional and functional differences with mouse. Neuron 89:
37 – 53
Zhao JJ, Liu Z, Wang L, Shin E, Loda MF, Roberts TM (2005) The oncogenic
properties of mutant p110alpha and p110beta phosphatidylinositol 3-
kinases in human mammary epithelial cells. Proc Natl Acad Sci USA 102:
18443 – 18448
Zhou FQ, Zhou J, Dedhar S, Wu YH, Snider WD (2004) NGF-induced axon
growth is mediated by localized inactivation of GSK-3beta and
functions of the microtubule plus end binding protein APC. Neuron 42:
897 – 912
License: This is an open access article under the
terms of the Creative Commons Attribution 4.0
License, which permits use, distribution and reproduc-
tion in any medium, provided the original work is
properly cited.
24 of 24 EMBO Molecular Medicine 12: e11674 | 2020 ª 2020 The Authors
EMBO Molecular Medicine Bart Nieuwenhuis et al
